_id

690dafd3ccc777a4e85d0b30

Ticker

APLT

Name

Applied Therapeutics Inc

Exchange

NASDAQ

Address

545 Fifth Avenue, New York, NY, United States, 10017

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.appliedtherapeutics.com

Description

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company's lead product candidate is AT-007 that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, and for the treatment of phosphomannomutase enzyme-CDG. It develops AT-001 that is in phase 3 clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. The company has exclusive license and supply agreement with Mercury Pharma Group Limited to commercialize drug products containing AT-007. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Last Close

0.2169

Volume

6991458

Current Price

0.1173

Change

-45.91977869986169

Last Updated

2025-11-28T12:18:20.616Z

Image

data:image/webp;base64,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

Ipo Date

2019-05-14T00:00:00.000Z

Market Cap

38124236

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.97625

Sentiment Sources

4

Rating

4

Target Price

1.6667

Strong Buy

2

Buy

0

Hold

2

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

1000000

Cost Of Revenue

-

Gross Profit

1000000

Operating Expenses

17758000

Operating Income

-16758000

Interest Expense

-

Pretax Income

-18990000

Net Income

-18990000

Eps

-0.13046202021819187

Dividends Per Share

-

Shares Outstanding

144300674

Income Tax Expense

-

EBITDA

-18879000

Operating Margin

-1675.8

Total Other Income Expense Net

-2232000

Cash

11945000

Short Term Investments

-

Receivables

16653000

Inventories

-

Total Current Assets

31654000

Property Plant Equipment

2468000

Total Assets

34374000

Payables

4800000

Short Term Debt

467000

Long Term Debt

-

Total Liabilities

34935000

Equity

-561000

Depreciation

111000

Change In Working Capital

-2931000

Cash From Operations

-18401000

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

-75000

Net Change In Cash

-18476000

PE

-

PB

-30.435189927272727

ROE

3385.0267379679144

ROA

-55.24524349799267

FCF

-18401000

Fcf Percent

-18.401

Piotroski FScore

1

Health Score

31

Deep Value Investing Score

1.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

5.3

Garp Investing Score

2

Growth Investing Score

2

Momentum Investing Score

5.5

Net Net Investing Score

1

Quality Investing Score

2.5

Value Investing Score

2.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

1000000

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

1000000

Quarters > 0 > income Statement > operating Expenses

17758000

Quarters > 0 > income Statement > operating Income

-16758000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-18990000

Quarters > 0 > income Statement > net Income

-18990000

Quarters > 0 > income Statement > eps

-0.13046202021819187

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

145559604

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-18879000

Quarters > 0 > income Statement > operating Margin

-1675.8

Quarters > 0 > income Statement > total Other Income Expense Net

-2232000

Quarters > 0 > balance Sheet > cash

11945000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

16653000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

31654000

Quarters > 0 > balance Sheet > property Plant Equipment

2468000

Quarters > 0 > balance Sheet > total Assets

34374000

Quarters > 0 > balance Sheet > payables

4800000

Quarters > 0 > balance Sheet > short Term Debt

467000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

34935000

Quarters > 0 > balance Sheet > equity

-561000

Quarters > 0 > cash Flow > net Income

-18990000

Quarters > 0 > cash Flow > depreciation

111000

Quarters > 0 > cash Flow > change In Working Capital

-2931000

Quarters > 0 > cash Flow > cash From Operations

-18401000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

-75000

Quarters > 0 > cash Flow > net Change In Cash

-18476000

Quarters > 0 > ratios > PE

-0.13046202021819187

Quarters > 0 > ratios > PB

-30.435189927272727

Quarters > 0 > ratios > ROE

3385.0267379679144

Quarters > 0 > ratios > ROA

-55.24524349799267

Quarters > 0 > ratios > FCF

-18401000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-18.401

Quarters > 0 > health Score

31

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

9923000

Quarters > 1 > income Statement > gross Profit

-9923000

Quarters > 1 > income Statement > operating Expenses

13175000

Quarters > 1 > income Statement > operating Income

-23098000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-21330000

Quarters > 1 > income Statement > net Income

-21330000

Quarters > 1 > income Statement > eps

-0.14701070581170056

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

145091474

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-23097500

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

1768000

Quarters > 1 > balance Sheet > cash

30421000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

34511000

Quarters > 1 > balance Sheet > property Plant Equipment

2579000

Quarters > 1 > balance Sheet > total Assets

37342000

Quarters > 1 > balance Sheet > payables

4861000

Quarters > 1 > balance Sheet > short Term Debt

447000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

19904000

Quarters > 1 > balance Sheet > equity

17438000

Quarters > 1 > cash Flow > net Income

-21330000

Quarters > 1 > cash Flow > depreciation

110000

Quarters > 1 > cash Flow > change In Working Capital

314000

Quarters > 1 > cash Flow > cash From Operations

-20341000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

0

Quarters > 1 > cash Flow > net Change In Cash

-20341000

Quarters > 1 > ratios > PE

-0.14701070581170056

Quarters > 1 > ratios > PB

0.9759851990021792

Quarters > 1 > ratios > ROE

-122.31907328822113

Quarters > 1 > ratios > ROA

-57.120668416260514

Quarters > 1 > ratios > FCF

-20341000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

32

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

-1000

Quarters > 2 > income Statement > cost Of Revenue

7837000

Quarters > 2 > income Statement > gross Profit

-7837000

Quarters > 2 > income Statement > operating Expenses

17688000

Quarters > 2 > income Statement > operating Income

-25525000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-21825000

Quarters > 2 > income Statement > net Income

-21825000

Quarters > 2 > income Statement > eps

-0.15073763019034728

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

144788000

Quarters > 2 > income Statement > income Tax Expense

119000

Quarters > 2 > income Statement > EBITDA

-25524750

Quarters > 2 > income Statement > operating Margin

2552500

Quarters > 2 > income Statement > total Other Income Expense Net

3700000

Quarters > 2 > balance Sheet > cash

50762000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

53966000

Quarters > 2 > balance Sheet > property Plant Equipment

2688000

Quarters > 2 > balance Sheet > total Assets

56907000

Quarters > 2 > balance Sheet > payables

4868000

Quarters > 2 > balance Sheet > short Term Debt

426000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

20239000

Quarters > 2 > balance Sheet > equity

36668000

Quarters > 2 > cash Flow > net Income

-21825000

Quarters > 2 > cash Flow > depreciation

104000

Quarters > 2 > cash Flow > change In Working Capital

-5203000

Quarters > 2 > cash Flow > cash From Operations

-28636000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

0

Quarters > 2 > cash Flow > net Change In Cash

-28636000

Quarters > 2 > ratios > PE

-0.15073763019034728

Quarters > 2 > ratios > PB

0.46317313188611325

Quarters > 2 > ratios > ROE

-59.52056288862223

Quarters > 2 > ratios > ROA

-38.35204807844378

Quarters > 2 > ratios > FCF

-28636000

Quarters > 2 > ratios > Piotroski FScore

0

Quarters > 2 > ratios > fcf Percent

28636

Quarters > 2 > health Score

47

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

0

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

-

Quarters > 3 > income Statement > operating Expenses

33022000

Quarters > 3 > income Statement > operating Income

-33022000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

44007000

Quarters > 3 > income Statement > net Income

44007000

Quarters > 3 > income Statement > eps

0.3206835512686078

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

137228741

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-

Quarters > 3 > income Statement > operating Margin

-

Quarters > 3 > income Statement > total Other Income Expense Net

76067000

Quarters > 3 > balance Sheet > cash

79398000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

83646000

Quarters > 3 > balance Sheet > property Plant Equipment

2792000

Quarters > 3 > balance Sheet > total Assets

86691000

Quarters > 3 > balance Sheet > payables

4433000

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

29685000

Quarters > 3 > balance Sheet > equity

57006000

Quarters > 3 > cash Flow > net Income

44007000

Quarters > 3 > cash Flow > depreciation

80000

Quarters > 3 > cash Flow > change In Working Capital

5485000

Quarters > 3 > cash Flow > cash From Operations

-19469000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

0

Quarters > 3 > cash Flow > net Change In Cash

-19469000

Quarters > 3 > ratios > PE

0.3206835512686078

Quarters > 3 > ratios > PB

0.28237258041785074

Quarters > 3 > ratios > ROE

77.19713714345858

Quarters > 3 > ratios > ROA

50.7630549884071

Quarters > 3 > ratios > FCF

-19469000

Quarters > 3 > ratios > Piotroski FScore

2

Quarters > 3 > ratios > fcf Percent

-

Quarters > 3 > health Score

77

Valuation > metrics > PE

-0.13046202021819187

Valuation > metrics > PB

-30.435189927272727

Valuation > final Score

50

Valuation > verdict

Fair

Profitability > metrics > ROE

3385.0267379679144

Profitability > metrics > ROA

-59.99241801983951

Profitability > metrics > Net Margin

-18.99

Profitability > final Score

40

Profitability > verdict

Weak

Risk > metrics > Interest Coverage

-150.97297297297297

Risk > final Score

-574

Risk > verdict

High

Liquidity > metrics > Current Ratio

6.009872792861211

Liquidity > metrics > Quick Ratio

6.009872792861211

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

90

Prev Profitabilities > 0

15

Prev Profitabilities > 1

30

Prev Profitabilities > 2

85

Prev Risks > 0

-22

Prev Risks > 1

20

Prev Risks > 2

46

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:14:01.282Z